The short answer
Ashwagandha is not a general-purpose stress, sleep, testosterone or performance treatment. NCCIH's evidence and safety review[1] says some preparations may help stress or insomnia, while studies are small and heterogeneous and long-term safety is uncertain. Rare liver injury has been reported, and the herb should be avoided in pregnancy and breastfeeding and used cautiously with thyroid, immune, blood-pressure, diabetes, sedative and seizure medicines.
In this article
If symptoms are persistent, severe or affecting daily life, seek assessment rather than using a product as a diagnostic test.
Decide whether this is a supplement question
| Situation | Better next step |
|---|---|
| Acute stress from workload or disrupted routine | Address the stressor, sleep opportunity and support first |
| Persistent anxiety, panic, low mood or trauma symptoms | Use a GP/mental-health pathway |
| Chronic insomnia or loud snoring/gasping | Assess insomnia/sleep apnoea rather than self-sedating |
| Seeking higher testosterone or fertility | Use clinical testing/assessment; do not infer deficiency |
| Pregnancy, breastfeeding, thyroid/autoimmune disease or surgery planned | Avoid/self-withhold and ask the clinician |
| Taking several medicines or herbs | Obtain a pharmacist interaction review |
For general food and training support, see Inception Nutrition and Inception Gym. Use a registered dietitian for clinical nutrition advice and verify each provider's qualifications and scope.
“Ashwagandha” does not identify one intervention
Withania somnifera products may use root, leaf, both, or extracts standardised to different withanolide measures. Extraction solvent, withanolide method, dose and other ingredients differ. Results from one named extract cannot automatically substantiate another.
| Label item | Why it matters |
|---|---|
| Plant name | Confirms Withania somnifera rather than a marketing blend |
| Plant part | Root and leaf products are not identical |
| Extract ratio | A 10:1 statement needs raw-material and extraction context |
| Standardisation | “5% withanolides” depends on analytical method |
| Daily dose | Trial matching requires extract amount and frequency |
| Batch testing | Identity, microbes, pesticides, heavy metals and adulterants |
“Clinically studied” may mean the ingredient supplier funded a trial on its own extract. Check funding/conflicts and whether the retail product matches the formulation.
What stress and sleep studies show
Systematic reviews find possible reductions in perceived stress and small improvements in some sleep outcomes. Confidence is limited by small samples, short follow-up, differing extracts and questionnaires, and publication bias. A change in a cortisol laboratory value is not the same as improved function or treatment of an anxiety disorder.
NCCIH concludes that some preparations may help insomnia and stress, while evidence for anxiety remains unclear. It finds insufficient evidence for athletic performance, cognition, diabetes, menopause and most other promoted uses. A product claim needs to be judged against those limits.
Testosterone and training claims
Limited trials over two to four months suggest possible testosterone or sperm-quality changes in selected groups, but this is not a reliable “test booster” result for all adults. Reviews of testosterone-booster ingredients find inconsistent evidence and few direct trials of complete retail products.
Training studies cannot separate the plant from the exact extract, dose, programme and participant group. Do not promise strength, muscle gain, recovery or hormonal optimisation.
Safety is more than stomach upset
Short-term use up to about three months appears tolerated in many studies, but NCCIH says there is not enough information for long-term safety conclusions. Drowsiness, stomach upset, diarrhoea and vomiting can occur.
Rare but potentially serious liver injury has been linked to ashwagandha. LiverTox describes case reports typically presenting with jaundice and itching after weeks of use; causality can be difficult because supplements vary and other exposures exist. Stop the product and seek urgent assessment for yellow skin/eyes, dark urine, pale stools, severe itching or persistent upper-abdominal symptoms.
Who should avoid or obtain medical advice
NCCIH advises avoiding ashwagandha during pregnancy and breastfeeding, before surgery, and in autoimmune or thyroid disorders. Potential interactions include medicines for diabetes and high blood pressure, immunosuppressants, sedatives, anticonvulsants and thyroid hormone.
People with hormone-sensitive prostate cancer should avoid it because of possible testosterone effects. Liver disease or previous supplement-related liver injury also warrants clinical advice.
Do not simply stop a prescribed medicine to make an herb “fit.” Bring the exact ingredient list to the prescriber or pharmacist.
Run a cautious, interpretable trial only when appropriate
If a pharmacist/clinician agrees that a short trial is suitable:
- Choose one product with transparent extract and batch information.
- Define one outcome, such as a validated sleep diary or perceived-stress scale.
- Keep other supplements stable.
- Set a stop/review date within the short-term safety evidence.
- Record adverse effects and stop for liver-warning symptoms.
This is not a recommendation to use ashwagandha. It is a way to reduce confusion if use has been approved.
Frequently asked questions
Does ashwagandha lower cortisol?
Some small trials report changes, but cortisol varies with timing and stress, and a lab change does not establish treatment of “high cortisol.”
Is KSM-66 better than Sensoril?
They are different proprietary extracts studied in different trials. No strong independent head-to-head evidence establishes a universal winner. Compare exact evidence and conflicts of interest.
Can I take it with thyroid medicine?
Do not self-combine. Thyroid effects and interactions have been reported; use prescriber/pharmacist advice and monitoring.
Is it safe long term?
Long-term safety is not established. NCCIH describes short-term evidence only, up to around three months.
Can it replace anxiety or insomnia treatment?
No. Persistent symptoms deserve assessment and evidence-based care. A supplement should not delay this.
References
- 1.NCCIH: Ashwagandha: usefulness and safety: evidence summary, short-term limit, pregnancy/breastfeeding, thyroid/autoimmune, surgery and medicine cautions.
- 2.NIH LiverTox: Ashwagandha: liver-injury case pattern and uncertainty.
- 3.Akhgarjand et al., 2022 systematic review/meta-analysis: stress/anxiety evidence, high heterogeneity and low-certainty limitations.
- 4.Cheah et al., 2021 sleep meta-analysis: sleep outcomes, subgroup findings and short follow-up.
- 5.Systematic review of testosterone boosters: ingredient-level evidence and lack of complete-product certainty.
- 6.Health New Zealand: Dietary supplements: NZ safety, interaction and label framework.
- 7.Medsafe: Supplying products that are not approved medicines and ASA Therapeutic and Health Advertising Code: therapeutic-purpose and commercial-claim boundaries.
This guide provides general education, not diagnosis or individual medical advice. Follow product labels and speak with an appropriately qualified health professional when you are pregnant, nursing, taking medication or managing a health condition.
Keep learning
